Clinical Trial Update: Testosterone, Metformin, or Both, for Hypogonadism in Obese Males [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating testosterone, metformin, or both for hypogonadism in obese men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Obesity

Drugs mentioned

• TESTOSTERONE (testosterone)
• metformin (metformin)

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Hypogonadism, Obesity | Phase 3 | Status: COMPLETED